NEU 1.41% $15.81 neuren pharmaceuticals limited

Trading halt pending release of phase two Pitt Hopkins study....

  1. 2,847 Posts.
    lightbulb Created with Sketch. 533
    Trading halt pending release of phase two Pitt Hopkins study. Been here before with Rhett Syndrome results. Share price appreciation leading into event suggest a positive result coming, imho.
    Good luck to all holders and hopefully a good result for those living with Pitt Hopkins also.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$15.81
Change
0.220(1.41%)
Mkt cap ! $2.028B
Open High Low Value Volume
$15.68 $16.08 $15.32 $4.002M 253.0K

Buyers (Bids)

No. Vol. Price($)
3 85 $15.80
 

Sellers (Offers)

Price($) Vol. No.
$15.82 980 15
View Market Depth
Last trade - 14.36pm 27/08/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.